Michael Accardi Headshot

Michael Accardi, PhD

Associate Director Safety Pharmacology

Michael graduated with a PhD from the Department of Pharmacology and Therapeutics at McGill University in 2015 with a specialization in central nervous system function and disorder, specifically the metabolic regulation of inhibitory and excitatory neurotransmission.

Upon graduation, Michael joined Citoxlab North America (now Charles River Laval) where he developed and validated several in vitro electrophysiological services such as the hERG cardiac in vitro assay and hippocampal seizure liability assay in several preclinical animal species (i.e., rat, dog, minipig, and non-human primate).

Michael remains active in the continued development of new in vitro services for both cardiac and central nervous system assays as well as within the preclinical Safety Pharmacology arena where he has been a member of the Safety Pharmacology Society since 2015 and a Diplomate in Safety Pharmacology since 2018. He also remains very active in basic research with 23 peer-review publications (including industry and academic research) in high-ranking neuroscience and science journals such as Journal of Neuroscience and Nature Communications.

LinkedIn Profile